GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 127 filers reported holding GOSSAMER BIO INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $12,816 | -96.9% | 5,906 | -82.9% | 0.00% | -100.0% |
| Q3 2022 | $414,939 | +61.0% | 34,636 | +12.5% | 0.00% | +100.0% |
| Q2 2022 | $257,712 | -15.7% | 30,790 | -12.6% | 0.00% | 0.0% |
| Q1 2022 | $305,883 | +19.3% | 35,240 | +55.4% | 0.00% | 0.0% |
| Q4 2021 | $256,454 | +22.3% | 22,675 | +35.9% | 0.00% | 0.0% |
| Q3 2021 | $209,768 | +5.5% | 16,688 | -31.8% | 0.00% | 0.0% |
| Q2 2021 | $198,769 | +92.6% | 24,479 | +119.4% | 0.00% | +100.0% |
| Q1 2021 | $103,202 | -53.6% | 11,157 | -51.5% | 0.00% | -50.0% |
| Q4 2020 | $222,391 | -22.1% | 22,998 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $285,405 | -4.5% | 22,998 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $298,974 | +50.0% | 22,998 | +17.1% | 0.00% | 0.0% |
| Q1 2020 | $199,356 | -35.1% | 19,641 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $306,989 | -6.9% | 19,641 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $329,772 | – | 19,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 4,275,726 | $43,399,000 | 17.96% |
| Boxer Capital, LLC | 2,185,000 | $22,178,000 | 1.51% |
| HHLR ADVISORS, LTD. | 5,911,541 | $60,002,000 | 0.81% |
| Artal Group S.A. | 1,808,968 | $18,361,000 | 0.78% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $4,667,000 | 0.46% |
| Spark Investment Management LLC | 39,906 | $405,000 | 0.22% |
| Alyeska Investment Group, L.P. | 476,838 | $4,840,000 | 0.10% |
| Cormorant Asset Management, LP | 198,382 | $2,014,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 36,101 | $366,000 | 0.09% |
| Redmile Group, LLC | 259,700 | $2,636,000 | 0.07% |